Incidence and treatment of prostate cancer in the region of the Comprehensive Cancer Centre Amsterdam (CCCA), 1989-994;Incidentie en behandeling van prostaatcarcinoom in de regio van het integraal kankercentrum Amsterdam, 1989-1994

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 52, 1996, Pages 2627-2631

  Visser, O ^a   Horenblas, S ^b  

^a Integraal Kankercentrum Amsterdam   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GOOD CLINICAL PRACTICE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PROSTATE CARCINOMA; PROSTATECTOMY; SURGERY;

AGED; AGED, 80 AND OVER; CANCER CARE FACILITIES; CARCINOMA; HORMONES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY;

EID: 0030478937     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Vereniging van Integrale Kankercentra (VvIK). Incidence of cancer in the Netherlands 1992. Utrecht: VvIK. 1995.
2. Catalona WJ, Smith DS, Rathff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993;270:948-54.
3. Mettlin C, Murphy GP, Lee F, Littrup PJ, Chesley A, Babaian R, et al. Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project. J Urol 1994;152:1737-40
4. Smith DS, Catalona WJ. The nature of prostate cancer detected through prostate specific antigen based screening. J Urol 1994;152: 1732-6.
5. Post PN. Prostate cancer. In: Coebergh JWW. Heijden LH van der, Janssen-Heijnen MLG. redacteuren. Cancer incidence and survival in the southeast of the Netherlands 1955-1994. Eindhoven: Integraal Kankercentrum Zuid. 1995:66-8.
6. International Union Against Cancer (UICC). TNM classification of malignant tumours. 4th ed. Berlin: Springer, 1987.
7. International Union Against Cancer (UICC). TNM classification of malignant tumours. 4th rev. ed. Berlin: Springer, 1992.
8. Partin AW, Yoo J. Carter HB, Pearson JD, Chan DW, Epstein JI, et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993;150:110-4.
9. Danley KL, Richardson JL, Bernstein L, Langholtz B, Ross RK. Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (Unites States). Cancer Causes Control 1995;6:492-8
10. Lerner SE, Blute ML, Zincke H. Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity. J Urol 1995;154:1447-52.
11. Ouden D van den, Davidson PJ, Hop W, Schröder FH. Radical prostatectomy as a monotherapy for locally advanced (stage T3) prostate cancer. J Urol 1994;151:646-51.
12. Werkgroep Urologische Tumoren. Behandelingsrichtlijnen prostaatcarcinoom. Amsterdam: Integraal Kankercentrum Amsterdam, 1995.